Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional, National Human Genome Research Institute's (NHGRI) ELSI Research Program
Funding Opportunity posted by Kelsey Middleton
Description:
Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional (RFA-HG-24-026) |
Who can apply?
Eligible applicants must be domestic organizations located in the United States and its territories that received less than $30 million per year in total NIH funding for the past three fiscal years (FY 2023 -2025). Eligible applicants may propose partnerships with other organizations that receive more than $30 million per year in NIH funding.
Students and trainees are not eligible to apply. Organizations outside of the United States are not eligible to apply.
What is this program?
The goals of the Building Partnerships and Broadening Perspectives to Advance ELSI Research (BBAER) Program are to 1) advance ELSI scholarship, 2) enhance ELSI research teams through partnerships with relevant communities, 3) build ELSI research capacity, and 4) expand the ELSI workforce. Collectively, these goals will broaden the types of knowledge, skills, expertise, experience, and perspectives brought to bear in ELSI research.
This program is funded by the National Human Genome Research Institute’s (NHGRI) ELSI Research Program. Since 1990, the ELSI Research Program has funded research, research training, resource development, and other activities addressing the ethical, legal, and social implications of advances in genetics and genomics.
How can I learn more?
Please see the Notice of Funding Opportunity RFA-HG-24-026 for detailed information about the program, including an overview diagram of all application elements. Responses to Frequently Asked Questions and a recorded presentation about the program are available online.
Feel free to contact Dr. Rene Sterling at rene.sterling@nih.gov to discuss your interests. Per NIH notice NOT-OD-26-019, letters of intent are no longer required.
Closing Date
Jul 31, 2026